Jump to main content
Jump to site search

Issue 39, 2013
Previous Article Next Article

A multimodal, β-amyloid-targeted contrast agent

Author affiliations

Abstract

A multimodal, β-amyloid-targeted contrast agent was synthesized and studied in vitro. The agent has a higher relaxivity than a clinically approved contrast agent and interacts with β-amyloid aggregates producing changes in relaxation rate and fluorescence emission.

Graphical abstract: A multimodal, β-amyloid-targeted contrast agent

Back to tab navigation

Supplementary files

Article information


Submitted
11 Sep 2012
Accepted
18 Oct 2012
First published
09 Nov 2012

Chem. Commun., 2013,49, 4148-4150
Article type
Communication

A multimodal, β-amyloid-targeted contrast agent

S. M. Vithanarachchi and M. J. Allen, Chem. Commun., 2013, 49, 4148
DOI: 10.1039/C2CC36583A

Social activity

Search articles by author

Spotlight

Advertisements